The estimated Net Worth of James M Kilts is at least $159 millió dollars as of 3 March 2024. Mr. Kilts owns over 18,855 units of Pfizer stock worth over $3,483,419 and over the last 21 years he sold PFE stock worth over $154,968,140. In addition, he makes $355,000 as Independent Director at Pfizer.
James has made over 25 trades of the Pfizer stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 18,855 units of PFE stock worth $559,239 on 3 March 2024.
The largest trade he's ever made was selling 1,610,933 units of Pfizer stock on 7 May 2014 worth over $75,713,851. On average, James trades about 27,356 units every 24 days since 2003. As of 3 March 2024 he still owns at least 117,445 units of Pfizer stock.
You can see the complete history of Mr. Kilts stock trades at the bottom of the page.
James Marshall Kilts serves as Independent Director of the Company. Director of MetLife, Inc., The Simply Good Foods Company and Unifi, Inc. Executive Chairman of the Board of Conyers Park II Acquisition Corp. (a special purpose acquisition company and an affiliate of Centerview Capital). Executive Chairman of the Board of Conyers Park Acquisition Corporation from 2016 until its merger with The Simply Good Foods Company in 2017. Non-Executive Director of the Board of Nielsen Holdings PLC from 2006 until 2017. Chairman of Big Heart Pet Brands until 2015. Life Trustee of Knox College and Trustee of the University of Chicago and Founder and Co-Chair, Steering Committee, of the Kilts Center for Marketing at the University of Chicago Booth School of Business. Mr. Kilts’ tenure as CEO of Gillette and Nabisco and as Vice Chairman of Procter & Gamble provides valuable business, leadership and management experience, including expertise in cost management, value creation and resource allocation. In addition, his knowledge of consumer businesses has given him insights into reaching consumers and the importance of innovation, both important aspects of Pfizer’s business. Through his service on various compensation committees, including ours, Mr. Kilts has a strong understanding of executive compensation and related areas.
As the Independent Director of Pfizer, the total compensation of James Kilts at Pfizer is $355,000. There are 14 executives at Pfizer getting paid more, with Albert Bourla having the highest compensation of $17,929,000.
James's mailing address filed with the SEC is 1225 17TH STREET, SUITE 1000, , DENVER, CO, 80202.
Over the last 12 years, insiders at Pfizer have traded over $216,003,942 worth of Pfizer stock and bought 24,324 units worth $872,198 . The most active insiders traders include Shantanu Narayen, Ian C Read és James M Kilts. On average, Pfizer executives and independent directors trade stock every 12 days with the average trade being worth of $2,169,896. The most recent stock trade was executed by Jennifer B. Damico on 13 August 2024, trading 5,154 units of PFE stock currently worth $147,714.
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
Pfizer executives and other stock owners filed with the SEC include: